1.1
Rituximab, in combination with glucocorticoids, is recommended as an option for inducing remission in adults with anti-neutrophil cytoplasmic antibody [ANCA]-associated vasculitis (severely active granulomatosis with polyangiitis [Wegener's] and microscopic polyangiitis), only if:
-
further cyclophosphamide treatment would exceed the maximum cumulative cyclophosphamide dose or
-
cyclophosphamide is contraindicated or not tolerated or
-
the person has not completed their family and treatment with cyclophosphamide may materially affect their fertility or
-
the disease has remained active or progressed despite a course of cyclophosphamide lasting 3–6 months or
-
the person has had uroepithelial malignancy.